Impax To Pay $4.8M To End 'Fax-Blasting' Suit
Pharmaceutical company Impax Laboratories Inc. will pay $4.8 million to end a proposed class action alleging it sent "blasts" of unsolicited faxes advertising a low-cost alternative to Mylan's EpiPen, according to...To view the full article, register now.
Already a subscriber? Click here to view full article